Galapagos NV
GLPG
#4956
Rank
A$2.61 B
Marketcap
A$38.89
Share price
0.00%
Change (1 day)
-12.14%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2026 (TTM): A$0.81 Billion

According to Galapagos NV's latest financial reports the company's current earnings are A$1.22 Billion. In 2025 the company made an earning of A$0.51 Billion, an increase over its 2024 earnings that were of -A$8.11 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.81 B58.29%
2025 A$0.51 B-6464.81%
2024 -A$8.11 Million-82.77%
2023 -A$47.05 Million-85.59%
2022 -A$0.33 Billion60.71%
2021 -A$0.21 Billion-60.08%
2020 -A$0.51 Billion-331.44%
2019 A$0.21 B-523.76%
2018 -A$51.91 Million-72.34%
2017 -A$0.19 Billion-329.59%
2016 A$81.73 M-144.3%
2015 -A$0.19 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.43 B 4,596.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.41 B 1,371.11%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$9.25 B 1,092.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.74 B 1,284.59%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$18.44 B 2,277.78%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.56 B 2,551.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$14.04 B 1,709.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-A$75 Million-109.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.18 B 310.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel